Syneron Medical Ltd. Stock Upgraded (ELOS)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK (TheStreet) -- Syneron Medical (Nasdaq:ELOS) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.

• EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:

• The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 94.3% when compared to the same quarter one year prior, rising from -$40.09 million to -$2.29 million.
• Despite its growing revenue, the company underperformed as compared with the industry average of 8.5%. Since the same quarter one year prior, revenues slightly increased by 5.5%. Growth in the company's revenue appears to have helped boost the earnings per share.
• SYNERON MEDICAL LTD reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, SYNERON MEDICAL LTD reported poor results of -$1.45 versus -$0.74 in the prior year. This year, the market expects an improvement in earnings ($0.19 versus -$1.45).
• Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, SYNERON MEDICAL LTD's return on equity significantly trails that of both the industry average and the S&P 500.
• ELOS has underperformed the S&P 500 Index, declining 6.37% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.

.

Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products worldwide. Syneron Medical has a market cap of $365.4 million and is part of the health care sector and health services industry. Shares are up 19% year to date as of the close of trading on Wednesday.

You can view the full Syneron Medical Ratings Report or get investment ideas from our investment research center.

-- Written by a member of TheStreet Ratings Staff

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

For more information on Syneron Medical Ltd. click any of the following:

• Syneron Medical Ltd. Stock Price

• Syneron Medical Ltd. Analyst Ratings

• Syneron Medical Ltd. Key Stats & Profile

• Syneron Medical Ltd. Earnings

• Syneron Medical Ltd. Ratio Comparison

• Syneron Medical Ltd. Growth Rates

• Syneron Medical Ltd. Balance Sheet

• Syneron Medical Ltd. Cash Flow

• Syneron Medical Ltd. Income Statement